This story is from our news.com.au network Source: AAP
Bird flu trial results due
February 16, 2006
EARLY results of an Australian bird flu vaccine trial will be released tomorrow.
Melbourne-based pharmaceutical manufacturer CSL will make public preliminary results of a clinical trial for a prototype pandemic vaccine designed to protect against the H5N1 avian influenza strain.
CSL began testing the vaccine on the first of 400 Australian volunteers in October last year to determine its safety and effectiveness.
The strain under trial was taken from a bird flu victim in Vietnam and neutralised to prevent it from being contagious.
bird flu
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$278.20 |
Change
-3.760(1.33%) |
Mkt cap ! $134.4B | |||
| Open | High | Low | Value | Volume |
| $279.50 | $280.30 | $278.20 | $220.7M | 791.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 12008 | $278.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $278.31 | 35 | 1 |
View Market Depth
| Last trade - 16.10pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$279.07 |
Change
-3.760 ( 0.97 %) |
||||
| Open | High | Low | Volume | ||
| $279.78 | $280.29 | $279.03 | 107046 | ||
| Last updated 15.59pm 29/05/2024 ? | |||||
| CSL (ASX) Chart |